Analysis of Gene Expression Using Gene Sets Discriminates Cancer Patients with and without Late Radiation Toxicity

Background Radiation is an effective anti-cancer therapy but leads to severe late radiation toxicity in 5%–10% of patients. Assuming that genetic susceptibility impacts this risk, we hypothesized that the cellular response of normal tissue to X-rays could discriminate patients with and without late radiation toxicity. Methods and Findings Prostate carcinoma patients without evidence of cancer 2 y after curative radiotherapy were recruited in the study. Blood samples of 21 patients with severe late complications from radiation and 17 patients without symptoms were collected. Stimulated peripheral lymphocytes were mock-irradiated or irradiated with 2-Gy X-rays. The 24-h radiation response was analyzed by gene expression profiling and used for classification. Classification was performed either on the expression of separate genes or, to augment the classification power, on gene sets consisting of genes grouped together based on function or cellular colocalization. X-ray irradiation altered the expression of radio-responsive genes in both groups. This response was variable across individuals, and the expression of the most significant radio-responsive genes was unlinked to radiation toxicity. The classifier based on the radiation response of separate genes correctly classified 63% of the patients. The classifier based on affected gene sets improved correct classification to 86%, although on the individual level only 21/38 (55%) patients were classified with high certainty. The majority of the discriminative genes and gene sets belonged to the ubiquitin, apoptosis, and stress signaling networks. The apoptotic response appeared more pronounced in patients that did not develop toxicity. In an independent set of 12 patients, the toxicity status of eight was predicted correctly by the gene set classifier. Conclusions Gene expression profiling succeeded to some extent in discriminating groups of patients with and without severe late radiotherapy toxicity. Moreover, the discriminative power was enhanced by assessment of functionally or structurally related gene sets. While prediction of individual response requires improvement, this study is a step forward in predicting susceptibility to late radiation toxicity.

[1]  Alexandra L Hanlon,et al.  Dose response in prostate cancer with 8-12 years' follow-up. , 2001, International journal of radiation oncology, biology, physics.

[2]  Kathleen F. Kerr,et al.  Standardizing global gene expression analysis between laboratories and across platforms , 2005, Nature Methods.

[3]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[4]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[5]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[6]  V. Cheung,et al.  Transcriptional response of lymphoblastoid cells to ionizing radiation. , 2003, Genome research.

[7]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[8]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[9]  Kenneth H Buetow,et al.  Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[11]  Dauid F. Percy Cluster Analysis (3rd Edition) , 1994 .

[12]  Trey Ideker,et al.  Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. , 2002, Molecular cancer research : MCR.

[13]  A. Begg,et al.  Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  J. Peacock,et al.  Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. , 2003, International journal of radiation oncology, biology, physics.

[15]  E. Dikomey,et al.  Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Westendorp,et al.  Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.

[17]  H. Bartelink,et al.  EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. , 1995, International journal of radiation oncology, biology, physics.

[18]  Harry Vrieling,et al.  Dissecting systems-wide data using mixture models: application to identify affected cellular processes , 2005, BMC Bioinformatics.

[19]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Molony,et al.  Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.

[21]  R. Tibshirani,et al.  Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Dahm-Daphi,et al.  Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  A. Kiltie,et al.  Detection of Individual Differences in Radiation-Induced Apoptosis of Peripheral Blood Lymphocytes in Normal Individuals, Ataxia Telangiectasia Homozygotes and Heterozygotes, and Breast Cancer Patients after Radiotherapy , 2000, Radiation research.

[24]  Thomas J. Begley,et al.  Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[27]  Sally A. Amundson,et al.  Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation , 2000, Radiation research.

[28]  P. Koper,et al.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.

[29]  Jacques Bernier,et al.  Late effects toxicity scoring: the SOMA scale , 1995 .

[30]  Michael Baumann,et al.  Towards genetic prediction of radiation responses: ESTRO's GENEPI project. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  A. Levine,et al.  A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.

[32]  Gilbert Chu,et al.  Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. , 2004, Nucleic acids research.

[33]  Anders Brahme,et al.  Biological Response to Radiation Therapy , 2003, Acta oncologica.

[34]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[35]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[36]  Tung‐Kwang Lee,et al.  Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. , 2002, International journal of radiation oncology, biology, physics.

[37]  R. Wurm,et al.  Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity , 1992, The Lancet.

[38]  A. Zwinderman,et al.  Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. , 1991, Mutation research.

[39]  Stefan Michiels,et al.  Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.

[40]  J. Ioannidis Microarrays and molecular research: noise discovery? , 2005, The Lancet.

[41]  J. Hendry,et al.  Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[42]  B. Weir,et al.  A systematic statistical linear modeling approach to oligonucleotide array experiments. , 2002, Mathematical biosciences.

[43]  H D Thames,et al.  Evidence for individual differences in the radiosensitivity of human skin. , 1992, European journal of cancer.

[44]  Hunter B. Fraser,et al.  Modularity and evolutionary constraint on proteins , 2005, Nature Genetics.

[45]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.